<http://schema.org/description>
"MannKind is developing a revolutionary new insulin called Afrezza, which could compete directly with Novo Nordisk&amp;#039;s\u00A0 NovaLog and Eli Lilly&amp;#039;s Humalog. Afrezza is\u00A0inhalable and"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/12/10/will-mannkind-inhale-novo-nordisks-profits/20786082/>